450 related articles for article (PubMed ID: 32843059)
1. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
Gericke B; Borsdorf S; Wienböker I; Noack A; Noack S; Löscher W
Fluids Barriers CNS; 2021 Aug; 18(1):36. PubMed ID: 34344390
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
[TBL] [Abstract][Full Text] [Related]
4. Studies of blood-brain barrier permeability of gastrodigenin in vitro and in vivo.
Mi Y; Mao Y; Cheng H; Ke G; Liu M; Fang C; Wang Q
Fitoterapia; 2020 Jan; 140():104447. PubMed ID: 31805306
[TBL] [Abstract][Full Text] [Related]
5. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
6. Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis.
Ma SC; Li Q; Peng JY; Zhouwen JL; Diao JF; Niu JX; Wang X; Guan XD; Jia W; Jiang WG
CNS Neurosci Ther; 2017 Dec; 23(12):947-960. PubMed ID: 28961379
[TBL] [Abstract][Full Text] [Related]
7. Parametric investigation of static and dynamic cell culture conditions and their impact on hCMEC/D3 barrier properties.
Hinkel S; Mattern K; Dietzel A; Reichl S; Müller-Goymann CC
Int J Pharm; 2019 Jul; 566():434-444. PubMed ID: 31163193
[TBL] [Abstract][Full Text] [Related]
8. Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.
Sajja RK; Green KN; Cucullo L
PLoS One; 2015; 10(3):e0122358. PubMed ID: 25807533
[TBL] [Abstract][Full Text] [Related]
9. Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells.
Luissint AC; Federici C; Guillonneau F; Chrétien F; Camoin L; Glacial F; Ganeshamoorthy K; Couraud PO
J Cereb Blood Flow Metab; 2012 May; 32(5):860-73. PubMed ID: 22333621
[TBL] [Abstract][Full Text] [Related]
10. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
[TBL] [Abstract][Full Text] [Related]
11. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells.
Qi D; Lin H; Hu B; Wei Y
J Control Release; 2023 Jun; 358():78-97. PubMed ID: 37076016
[TBL] [Abstract][Full Text] [Related]
12. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.
Masuda T; Hoshiyama T; Uemura T; Hirayama-Kurogi M; Ogata S; Furukawa A; Couraud PO; Furihata T; Ito S; Ohtsuki S
Mol Pharm; 2019 May; 16(5):2162-2171. PubMed ID: 30983357
[TBL] [Abstract][Full Text] [Related]
14. Lucifer Yellow - A Robust Paracellular Permeability Marker in a Cell Model of the Human Blood-brain Barrier.
Zhao W; Han L; Bae Y; Manickam DS
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475964
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport.
Veszelka S; Tóth A; Walter FR; Tóth AE; Gróf I; Mészáros M; Bocsik A; Hellinger É; Vastag M; Rákhely G; Deli MA
Front Mol Neurosci; 2018; 11():166. PubMed ID: 29872378
[TBL] [Abstract][Full Text] [Related]
16. A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes.
Thomsen LB; Burkhart A; Moos T
PLoS One; 2015; 10(8):e0134765. PubMed ID: 26241648
[TBL] [Abstract][Full Text] [Related]
17. Cryopreservation of human cerebral microvascular endothelial cells and astrocytes in suspension and monolayers.
Marquez-Curtis LA; Bokenfohr R; McGann LE; Elliott JAW
PLoS One; 2021; 16(4):e0249814. PubMed ID: 33852594
[TBL] [Abstract][Full Text] [Related]
18. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of miR-429 on expressions of ZO-1, Occludin, and Claudin-5 proteins to improve the permeability of blood spinal cord barrier
Sun R; Yu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Sep; 34(9):1163-1169. PubMed ID: 32929911
[TBL] [Abstract][Full Text] [Related]
20. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
